B38.2
Pulmonary coccidioidomycosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Pulmonary coccidioidomycosis, also known as Valley Fever, is a fungal infection primarily affecting the lungs. Caused by the inhalation of spores from the Coccidioides fungi, this condition is prevalent in certain arid regions of the southwestern United States, Mexico, Central America, and parts of South America. The disease can range from mild to severe, sometimes leading to complications if not properly managed. Recognizing the symptoms and understanding the causes can help in early diagnosis and treatment.
Causes & Symptoms
Clinical Causes: Inhalation of spores from Coccidioides fungi present in the soil Living or working in endemic areas with dusty environments Disturbing soil during construction or excavation activities Prolonged environmental exposure in regions with high fungal spore counts
Key Symptoms: Cough, which may be dry or produce sputum Chest pain or discomfort Fever and chills Fatigue and weakness Night sweats Shortness of breath Muscle or joint aches Headaches Skin rashes in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and laboratory tests. These may include:
Treatment Protocols: While some cases resolve without specific treatment, more severe or persistent infections often require antifungal medications. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is B38.2 a billable ICD-10 code?
Yes, B38.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B38.2?
Clinical documentation must specify the nature of Pulmonary coccidioidomycosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference